Rupali Insurance Company Limited (DSE:RUPALIINS)
22.30
-0.10 (-0.45%)
At close: Jul 31, 2025
Theseus Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Investments in Equity & Preferred Securities | - | 96.61 | 172.26 | 178.35 | 59.49 | 9.13 | Upgrade |
Other Investments | 326.1 | 178 | 154 | 130 | 106 | 82 | Upgrade |
Total Investments | 326.1 | 274.61 | 326.26 | 308.35 | 165.49 | 91.13 | Upgrade |
Cash & Equivalents | 680.52 | 663.8 | 775.94 | 927.24 | 1,033 | 1,068 | Upgrade |
Reinsurance Recoverable | - | 169.89 | 162.41 | 129.42 | 114.57 | 94.07 | Upgrade |
Other Receivables | 368.82 | 416.21 | 250.19 | 160.75 | 133.91 | 140.09 | Upgrade |
Property, Plant & Equipment | 451.04 | 355.51 | 335.62 | 356.38 | 399.98 | 391.64 | Upgrade |
Other Intangible Assets | - | 104.19 | 117.09 | 51.32 | 64.75 | 32.44 | Upgrade |
Other Current Assets | 818.91 | 592 | 577.21 | 554.29 | 543.04 | 530.09 | Upgrade |
Other Long-Term Assets | - | 77.61 | 72.41 | 155.91 | 109.41 | 92.73 | Upgrade |
Total Assets | 2,645 | 2,654 | 2,617 | 2,644 | 2,564 | 2,440 | Upgrade |
Accrued Expenses | - | 1.08 | -2.11 | -3.47 | 1.95 | 7.88 | Upgrade |
Insurance & Annuity Liabilities | 178 | 175.37 | 140.5 | 132.76 | 150.78 | 161.72 | Upgrade |
Unpaid Claims | 45.11 | 35.19 | 30.65 | 37.89 | 37.53 | 59.63 | Upgrade |
Unearned Premiums | 11.17 | 12.56 | 12.33 | 14.74 | 12.96 | 21.72 | Upgrade |
Reinsurance Payable | - | 44.83 | 41.41 | 24.87 | 27.25 | 42.71 | Upgrade |
Short-Term Debt | - | 80.17 | 84.81 | 74.75 | 80 | - | Upgrade |
Current Income Taxes Payable | - | 245.81 | 253.83 | 298.53 | 284.5 | 270.14 | Upgrade |
Long-Term Leases | - | 20.87 | 23.44 | 15.11 | 23.67 | - | Upgrade |
Long-Term Deferred Tax Liabilities | - | 23.07 | 19.95 | 15.35 | 20.39 | 12.51 | Upgrade |
Other Current Liabilities | 550.34 | 23.65 | 18.16 | 26.87 | 13.09 | - | Upgrade |
Other Long-Term Liabilities | 0 | 182.35 | 184.45 | 128.07 | 4.16 | 9.38 | Upgrade |
Total Liabilities | 784.62 | 846.71 | 809.21 | 767.25 | 658.08 | 587.47 | Upgrade |
Common Stock | 766.65 | 766.65 | 766.65 | 766.65 | 766.65 | 766.65 | Upgrade |
Additional Paid-In Capital | 212.45 | 212.45 | 212.45 | 212.45 | 212.45 | 212.45 | Upgrade |
Retained Earnings | 797.56 | 743.91 | 744.72 | 785.59 | 787.69 | 706.79 | Upgrade |
Comprehensive Income & Other | 84.1 | 84.1 | 84.1 | 111.73 | 139.37 | 167 | Upgrade |
Shareholders' Equity | 1,861 | 1,807 | 1,808 | 1,876 | 1,906 | 1,853 | Upgrade |
Total Liabilities & Equity | 2,645 | 2,654 | 2,617 | 2,644 | 2,564 | 2,440 | Upgrade |
Filing Date Shares Outstanding | 76.67 | 76.67 | 76.67 | 76.67 | 76.67 | 76.67 | Upgrade |
Total Common Shares Outstanding | 76.67 | 76.67 | 76.67 | 76.67 | 76.67 | 76.67 | Upgrade |
Total Debt | - | 101.03 | 108.25 | 89.87 | 103.67 | - | Upgrade |
Net Cash (Debt) | 680.52 | 562.76 | 667.68 | 837.38 | 929.42 | 1,068 | Upgrade |
Net Cash Growth | -12.20% | -15.71% | -20.27% | -9.90% | -12.99% | 0.27% | Upgrade |
Net Cash Per Share | 8.88 | 7.34 | 8.71 | 10.92 | 12.12 | 13.93 | Upgrade |
Book Value Per Share | 24.27 | 23.57 | 23.58 | 24.48 | 24.86 | 24.17 | Upgrade |
Tangible Book Value | 1,861 | 1,703 | 1,691 | 1,825 | 1,841 | 1,820 | Upgrade |
Tangible Book Value Per Share | 24.27 | 22.21 | 22.05 | 23.81 | 24.02 | 23.75 | Upgrade |
Land | - | 119.14 | 119.14 | 119.14 | 119.14 | 119.14 | Upgrade |
Buildings | - | 553.89 | 538.71 | 538.63 | 538.51 | 517.55 | Upgrade |
Machinery | - | 188.33 | 174.22 | 175.48 | 179.95 | 179.13 | Upgrade |
Updated Nov 10, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.